Sichuan, China

Min Luo

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Sichuan University, Institute of Applied Electronics, Caep. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Luo. Retrieved from https://idiyas.com/inventor/min-luo-l7pm44p3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

 

Average Co-Inventor Count = 4.4

ph-index = 1


Location History:

  • Sichuan, CN (2019)
  • Chengdu, CN (2020)

Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Min Luo: Innovator in Medical Technology

Introduction

Min Luo is a distinguished inventor based in Sichuan, China. He has made significant contributions to the field of medical technology, particularly in the development of predictive models and immunologic adjuvants. With a total of 3 patents, his work focuses on enhancing patient care and vaccine development.

Latest Patents

Min Luo's latest patents include innovative methods and systems aimed at improving healthcare outcomes. One of his notable inventions is a construction method, prediction system, and storage medium of an ADR (Adverse Drug Reaction) prediction model for elderly patients. This method involves constructing ADR trigger entries for elderly patients and combining evidence-based evaluation results to create a dataset of risk factors related to ADRs. The process includes annotating risk factors and ADR discrimination, ultimately training a machine learning model to obtain an ADR risk prediction model tailored for elderly patients.

Another significant patent is the alhydrogel-sodium chloride compound immunologic adjuvant, which addresses the need for effective immunologic adjuvants in biological medicine. This invention provides a novel solution by utilizing sodium chloride in the preparation of immunologic adjuvants. The resulting compound is characterized by its simplicity, low cost, strong immune activity, and high clinical safety, making it a valuable asset in vaccine development.

Career Highlights

Min Luo has worked with prominent institutions such as Sichuan University and the Institute of Applied Electronics, CAEP. His experience in these organizations has allowed him to collaborate on various innovative projects that bridge the gap between research and practical applications in medicine.

Collaborations

Throughout his career, Min Luo has collaborated with notable colleagues, including Qiang Kang and Guangyao Luo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical technology.

Conclusion

Min Luo's contributions to the field of medical technology through his patents and collaborations highlight his commitment to improving healthcare for elderly patients and advancing vaccine development. His innovative approaches continue to pave the way for future advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…